Image credit: FDA

FDA Reopens CBD Public Comment, “Extending It Indefinitely”

The Agency is specifically looking to collect “scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”

CBD
United States

As Congress Considers Cannabis, Regulators and Lawmakers Convene on Key Issues

A cannabis regulation panel brought together federal lawmakers and regulators, who focused on impairment, science, and efforts at the federal level to change cannabis policy.